Form 13-F position report

CYMABAY THERAPEUTICS INC

Reported by Boxer Capital LLC

CBAY CUSIP 23257D103 Manager CIK 0001465837

Reported 0 shares, down 4,000,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 19 Through Q3 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2020-03-31 2960000
2020-06-30 6980000
2020-09-30 28960000
2020-12-31 22960000
2021-03-31 18160000
2021-06-30 17440000
2021-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for CYMABAY THERAPEUTICS INC held by Boxer Capital LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2021 Reduced 0 -4,000,000 (-100.0%) 0 $0 2021-11-15
Q2 2021 Unchanged 4,000,000 0 (0.0%) 0.62% $17,440,000 2021-08-16
Q1 2021 Unchanged 4,000,000 0 (0.0%) 0.62% $18,160,000 2021-05-17
Q4 2020 Unchanged 4,000,000 0 (0.0%) 0.74% $22,960,000 2021-02-16
Q3 2020 Added 4,000,000 +2,000,000 (100.0%) 1.0% $28,960,000 2020-11-16
Q2 2020 Unchanged 2,000,000 0 (0.0%) 0.31% $6,980,000 2020-08-14
Q1 2020 Unchanged 2,000,000 0 (0.0%) 0.2% $2,960,000 2020-05-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

124 managers reported CYMABAY THERAPEUTICS INC for Q3 2021.

Managers reporting CYMABAY THERAPEUTICS INC in Q3 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Avoro Capital Advisors LLC Unchanged 10,300,000 0 0.59% $37,595,000 11 qtrs
BlackRock Inc Reduced 5,205,478 -226,192 < 0.01% $19,001,000 19 qtrs
COMMODORE CAPITAL LP Added 4,169,896 +640,431 4.01% $15,220,000 4 qtrs
VANGUARD GROUP INC Added 3,345,308 +18,526 < 0.01% $12,211,000 29 qtrs
BAKER BROS ADVISORS LP Unchanged 2,170,464 0 0.03% $7,922,000 6 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 1,958,653 -144,159 < 0.01% $7,149,000 19 qtrs
Foresite Capital Management IV LLC Unchanged 1,787,094 0 0.96% $6,523,000 16 qtrs
ADAGE CAPITAL PARTNERS GP L L C Unchanged 1,450,000 0 0.01% $5,293,000 28 qtrs
JPMorgan Chase & Co Added 1,331,275 +1,301,429 < 0.01% $4,860,000 15 qtrs
STATE STREET CORPORATION Reduced 1,276,967 -80,257 < 0.01% $4,661,000 17 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2021
Filed
November 15, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.